MIM
HUMA icon

Monashee Investment Management’s Humacyte HUMA Stock Holding History

Monashee Investment Management’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,000,000
Closed -$3.41M – 67
2025
Q1 		$3.41M Buy
+2,000,000
New +$7.51M 0.4% 33
2024
Q4 		– Sell
-535,000
Closed -$2.91M – 63
2024
Q3 		$2.91M Buy
535,000
+255,000
+91% +$1.68M 0.32% 50
2024
Q2 		$1.34M Sell
280,000
-720,000
-72% -$3.75M 0.17% 51
2024
Q1 		$3.11M Buy
+1,000,000
New +$3.36M 0.37% 52
2022
Q1 		– Sell
-399,910
Closed -$2.9M – 41
2021
Q4 		$2.9M Sell
399,910
-350,090
-47% -$3.46M 0.72% 25
2021
Q3 		$8.71M Buy
+750,000
New +$8.58M 1.61% 6

Other funds holding HUMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $2.04B AUM 35.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Monashee Investment Management's HUMA Position: Q2 2025 in Review

Monashee Investment Management sold out of Humacyte (HUMA) in Q2 2025, closing a stake of 2,000,000 shares — an estimated $3.41M sold.

Monashee Investment Management first reported a position in HUMA in Q3 2021 and held it in 6 quarters. The position peaked at $8.71M in Q3 2021. 156 funds tracked by Wall St. Rank hold HUMA as of Q2 2025.

  • Monashee Investment Management reported no remaining Humacyte position as of Q2 2025 after selling out during the quarter.
  • Monashee Investment Management sold 2,000,000 Humacyte shares in Q2 2025, an estimated $3.41M.
  • Monashee Investment Management first reported a position in Humacyte in Q3 2021 and held it in 6 quarters.
  • Monashee Investment Management's Humacyte position peaked at $8.71M in Q3 2021.
  • 156 funds tracked by Wall St. Rank held Humacyte as of Q2 2025.

Based on Monashee Investment Management's 13F filing for Q2 2025, filed 11 Aug 2025.